 |
|
Tuberculosis—A Global Problem Requiring a Global Solution
Catherine D. DeAngelis, MD, MPH;
Annette Flanagin, RN, MA
JAMA. 2005;293:2793-2794.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Tuberculosis (TB) continues its 3000-year history of decimation,1 currently infecting one third of the world’s population and killing approximately 2 million individuals annually.2-3
Some developed countries, such as the United States, have had declining numbers of individuals infected with TB over the past decade, but 23 countries account for 80% of all new TB cases, with more than half concentrated in 5 countries (Bangladesh, China, India, Indonesia, and Nigeria).4 Most new cases in the United States, and probably a substantial proportion of new cases in other developed countries, occur among individuals born in other countries. Clearly, TB is a global health problem.
The articles in this theme issue of JAMA devoted to TB address a number of important concerns including screening; treatment for active and latent infections; multidrug-resistant strains; and improving screening, treatment, and quality of care for all vulnerable populations. . . . [Full Text of this Article]
Author Affiliations: Dr DeAngelis is Editor-in-Chief (cathy.deangelis@jama-archives.org) and Ms Flanagin is Managing Deputy Editor, JAMA.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Characterization of the mycobacterial chromosome segregation protein ParB and identification of its target in Mycobacterium smegmatis
Jakimowicz et al.
Microbiology 2007;153:4050-4060.
ABSTRACT
| FULL TEXT
Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth
Long et al.
J Antimicrob Chemother 2007;59:118-121.
ABSTRACT
| FULL TEXT
Comparison of an In-house and a Commercial RD1-based ELISPOT-IFN-{gamma} Assay for the Diagnosis of Mycobacterium tuberculosis Infection
Mantegani et al.
Clin Med Res 2006;4:266-272.
ABSTRACT
| FULL TEXT
An In-House RD1-Based Enzyme-Linked Immunospot-Gamma Interferon Assay Instead of the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection.
Codecasa et al.
J. Clin. Microbiol. 2006;44:1944-1950.
ABSTRACT
| FULL TEXT
PCR Amplification of the IS6110 Insertion Element of Mycobacterium tuberculosis in Fecal Samples from Patients with Intestinal Tuberculosis.
Balamurugan et al.
J. Clin. Microbiol. 2006;44:1884-1886.
ABSTRACT
| FULL TEXT
|
